Dr. Rosen recalls if B-cell lymphoma is often a fatal diagnosis.
B-cell lymphomas may be fatal. Not all B-cell lymphomas, however, will take the individual’s life if treated appropriately. Ironically, the more aggressive B-cell lymphomas are the ones we can cure, and the cure rates can range from 20 to 80% depending on the nature of the lymphoma and the stage of lymphoma.
There’s another subset of lymphomas that are indolent, very slowly progressive. In that instance, we cannot cure the disease, but we can have a profound effect on prolonging life and improving quality of life.
About Dr. Steven Rosen, M.D., F.A.C.P:
Steven Rosen, M.D., F.A.C.P., is Genevieve Teuton Professor of Medicine, at the Feinberg School of Medicine, Northwestern University and Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Director of Cancer Programs at Northwestern Memorial Hospital. Following his graduation with distinction from Northwestern University Medical School's Six-Year Honors Program in 1976, Dr. Rosen completed his residency in Internal Medicine at Northwestern and a fellowship in Medical Oncology at the National Cancer Institute. Dr. Rosen's laboratory research focuses on experimental therapeutics and hematologic malignancies.